A recent survey reveals that 81% of UK citizens believe dementia should be a primary focus of national healthcare. The Alzheimer's Society is now calling on the new Prime Minister, Andy Burnham, to translate this public demand into concrete policy changes.
The 81 per cent mandate for dementia priority
Public sentiment in the UK shows a stark divide between citizen expectations and government performance regarding cognitive health. According to a poll of 1,000 people conducted by the Alzheimer's Society, 81 per cent of respondents want dementia to be treated as a national healthcare priority. However, only 15 per cent of those surveyed believe the current government is doing sufficient work to prepare for the increasing number of cases across the country.
This gap in perception suggests a significant political opportunity for the administration. The Alzheimer's Society report indicates that 52 per cent of voters would be more inclined to support a political party that explicitly commits to increasing funding for dementia care. This suggests that cognitive health is no longer just a medical issue, but a potent electoral lever.
An 18-week diagnosis target and the need for a dementia tsar
To move beyond rhetoric, the Alzheimer's Society has presented the Prime Minister with five specific demands. Central to these is the implementation of an 18-week diagnosis target to ensure patients are not left in limbo. Additionally, the organization is calling for the appointment of a new dementia tsar to oversee strategy and a comprehensive plan to manage the rollout of emerging medical treatments.
These demands are part of the broader "Defeating Dementia" campaign, which seeks to elevate the disease's profile to boost research and early detection. As reported in the source, the goal is to move the healthcare system toward a model where diagnosis is proactive rather than reactive, preventing patients from slipping through the cracks of a strained system.
Andy Burnham's personal link to Alzheimer's and the Makerfield connection
Prime Minister Andy Burnham enters this debate with a personal stake, having spoken openly about his father's struggle with Alzheimer's. This personal history is echoed by constituents in his home area of Makerfield, such as Andrea Yates, whose father Michael—a joinery business owner for 45 years—was diagnosed with the disease in 2023. Yates expressed hope that Burnham's personal experience would drive a shift in how the state cares for those who have contributed to the country for decades.
The intersection of Burnham's personal grief and his political authority creates a high-stakes environment. For the electorate, the Prime Minister's familiarity with the disease is seen as a prerequisite for empathy, but the success of his tenure will be measured by whether that empathy converts into legislative action for the million other people in similar positions.
The 'second-class citizen' treatment within the NHS
The push for reform is driven by allegations of systemic neglect within the National Health Service (NHS). Michelle Dyson, the chief executive of the Alzheimer's Society and a former senior official at the Department of Health and Social Care, has accused the NHS of treating dementia patients as "second-class citizens." Dyson claims that patients are often "cast aside" and sent home with little more than an informational leaflet rather than a comprehensive care plan.
This systemic failure reflects a wider crisis in UK social care, where the lack of integrated support often leaves families to manage complex neurological declines without professional guidance. by framing the issue as a matter of dignity and citizenship , the Alzheimer's Society is positioning dementia care as a fundamental right rather than a luxury of the wealthy.
Who will fund the rollout of new blood tests and drugs?
While the source mentions that new blood tests for diagnosis and innovative treatments are already a "reality," it leaves several critical questions unanswered. Specifically, the report does not detail how the NHS intends to fund these expensive new therapies or how the government will ensure equitable access across different regions of the UK.
Furthermore, the source does not provide the current average wait time for a dementia diagnosis, making it difficult to gauge exactly how ambitious the proposed 18-week target actually is. It remains unclear whether the proposed "dementia tsar" would have actual budgetary authority or serve merely as an advisory role.
Comments 0